Pay in 4 interest-free payments of $6.42 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
Pfizer's danuglipron, once considered the primary competitor, was discontinued in April 2025 after a case of potential drug-induced liver injury in a dose-optimization study, following the earlier termination of lotiglipron in 2023 for similar hepatic concerns
You earn $10 after their first visit
Safety and efficacy of tirzepatide as an add-on to single oral antihyperglycaemic medication in patients with type 2 diabetes in Japan (SURPASS J-combo): A multicentre, randomised, open-label, parallel-group, phase 3 trial
Glucagon is another hormone that your pancreas makes to help regulate blood glucose (sugar) levels
US$ 28.97
US$ 27.10
US$ 26.09
US$ 27.25
US$ 20.93
